JPRN-UMIN000024108未知1 期
Phase I/II study of transarterial marker placement for particle beam therapy for hepatocellular carcinoma - Phase I/II study of transarterial marker placement for particle beam therapy for hepatocellular carcinoma
适应症
试验速览
- 阶段
- 1 期
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Allergic reaction to contrast agent
研究者
相似试验
未知
1 期
Phase I/II study of transarterial marker placement for particle beam therapy for hilar cholangiocarcinomahilar cholangiocarcinomaJPRN-UMIN000026281Hyogo Ion Beam Medical Center20
未知
1 期
Phase I/II study of transarterial marker placement for particle beam therapy for intrahepatic cholangiocarcinomaintrahepatic cholangiocarcinomaJPRN-UMIN000026282Hyogo Ion Beam Medical Center20
已完成
2 期
Phase II study of segmental transcatheter arterial chemoembolization using iodinated oil mixed with cisplatin powder for unresectable hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000020810ara Medical University20
已完成
1 期
Phase 1/2 trial of TAME(:Transcatheter arterial micro embolization) for chronic musculoskeletal pain refractory to non-surgical managementMusculoskeletal chronic pain refractory to non-surgical managementJPRN-UMIN000014591Edogawa Musculoskeletal Intervention Study Group33
进行中（未招募）
不适用
Phase II study evaluating transarterial chemoembolization (TACE) in combination with sorafenib for the treatment of advanced hepatocellular carcinoma (HCC) - TACE and sorafenib for HCChistologically proven advanced hepatocellular carcinoma (HCC) not suitable for resection or liver transplantation but without extrahepatic manifestations and without previous treatment for HCCMedDRA version: 9.1Level: LLTClassification code 10019828Term: Hepatocellular carcinoma non-resectableEUCTR2007-000730-40-DEHeinrich-Heine-Universität Düsseldorf